Hudson Mind offers ketamine therapy, stellate ganglion block, TMS, Spravato, and multi-modal protocols for people living with treatment-resistant depression, anxiety, and PTSD. Board-certified clinicians. 281 Broadway, Manhattan.
Most psychiatric treatment focuses on managing symptoms through medication and therapy. For many people, this is enough. For those who haven't found relief through conventional approaches, Hudson Mind offers something different.
Interventional psychiatry treats mental illness as a biological condition and addresses its neurological underpinnings directly — through targeted medical procedures rather than systemic medication. At Hudson Mind, that includes ketamine treatments, nerve blocks, and magnetic brain stimulation.
Ketamine has been used in medicine for over 50 years. TMS has been FDA-approved for depression since 2008. Stellate ganglion blocks have an established evidence base for PTSD. Hudson Mind brings these together in coordinated protocols for patients who need more than conventional psychiatry offers.
1
Rather than broadly adjusting neurotransmitter levels, our treatments act on specific brain circuits and nervous system structures involved in depression, anxiety, and trauma.
2
Most of our patients have tried one or more antidepressants or other psychiatric medications without adequate improvement. Our treatments operate on different biological mechanisms.
3
Hudson Mind can coordinate with your existing providers and can refer you to integration-focused therapists to support your treatment.
1
Rather than broadly adjusting neurotransmitter levels, our treatments act on specific brain circuits and nervous system structures involved in depression, anxiety, and trauma.
2
Most of our patients have tried one or more antidepressants or other psychiatric medications without adequate improvement. Our treatments operate on different biological mechanisms.
3
Hudson Mind can coordinate with your existing providers and refer you to integration-focused therapists to support your treatment.
Our treatments are considered for people who have not found adequate relief through conventional psychiatric approaches.
For patients who have tried one or more antidepressant treatments without adequate improvement. Ketamine and TMS offer biologically distinct alternatives to standard pharmacotherapy.
Complex and chronic PTSD including military trauma, childhood adversity, and assault. Stellate ganglion block targets sympathetic nervous system dysregulation associated with trauma. Often combined with ketamine.
Generalized anxiety, social anxiety, and panic disorder that has not responded to first-line treatment. Ketamine and SGB work on different neurological pathways than standard anti-anxiety medications.
Ketamine has been studied for acute suicidal ideation and may be considered for patients in distress. All patients are evaluated individually. If you are in crisis, please call 988.
TMS received FDA clearance for OCD in 2018. Ketamine is also being studied for obsessive-compulsive disorder. Both offer an option for patients who have not responded to standard treatments.
Depressive episodes in bipolar disorder can be difficult to treat with standard antidepressants. Ketamine and TMS may be considered as alternatives under careful psychiatric monitoring.
Each treatment targets a different neurological pathway. A thorough intake evaluation determines which approach — or combination — is right for you.
Transcranial magnetic stimulation uses focused magnetic pulses to stimulate neurons in areas of the brain associated with depression.
Hudson Mind's protocol SGB, ketamine, and vagus nerve hydrodissection in one plan for complex, co-occuring conditions.
Spravato® (esketamine) is the first FDA-approved nasal spray for treatment-resistant depression and MDD with suicidal ideation, given with monitoring.
A minimally invasive nerve block targeting the stellate ganglion, tied to the sympathetic stress response. Used for PTSD, chronic anxiety, and trauma.
Every patient begins with a thorough evaluation. Treatment is personalized — never one-size-fits-all.
1
An optional 30-minute complimentary call with a member of our intake team. We review your history, prior treatments, and what you're hoping to achieve. We'll be honest about whether and how we think we can help. No commitment required.
2
Before any treatment begins, you meet with a Hudson Mind provider for a 45-60 minute intake covering your history, diagnoses, prior trials, and goals. This informs your personalized treatment plan.
3
If paying privately, we will reach out to schedule your treatment right away. If your treatment requires an insurance authorization, we’ll start your authorization request as soon as possible. Most patients are able to start treatment within 2 days to 2 weeks of their evaluation
4
Hudson Mind CAN work with your existing therapist or can connect you with practitioners who specialize in follow-up support. Continuity of care is part of our treatment structure.
Our team will walk you through your options and help you take the next step — no pressure, no commitment required.
Treatments offered
5
TMS FDA approved
2008
Ketamine in clinical use
50+ yrs
Hudson Mind Team
You may be a candidate for treatment at Hudson Mind if you recognize several of the following.
Common questions about our treatments, location, and how to get started.
Our intake team responds within one business day. Discovery calls are free, confidential, and without obligation.
Ketamine therapy uses sub-anesthetic doses of IV ketamine to act on NMDA receptors and glutamate pathways in the brain — a different mechanism than traditional antidepressants. It is administered in a clinical setting over multiple sessions. Hudson Mind offers ketamine therapy in New York City for treatment-resistant depression, anxiety, PTSD, and suicidal ideation.
A stellate ganglion block (SGB) is a minimally invasive injection targeting a nerve cluster in the neck involved in the sympathetic stress response. Used for PTSD, chronic anxiety, and trauma-related symptoms. At Hudson Mind, SGB is offered both as a standalone treatment and as part of the Complete Neuro-Reset protocol.
It can be! TMS is FDA-approved for treatment-resistant depression and is covered by most major insurance plans in New York when patients have tried at least two antidepressants without adequate relief. Hudson Mind handles insurance verification and prior authorization following your intake evaluation. Call/text (646) 906-8703 or email mind@hudson.health to ask whether we’re in network with your specific plan.
Ketamine acts on glutamate and NMDA receptors rather than the serotonin or dopamine pathways targeted by most antidepressants. This means it can be considered for patients who have not responded to SSRIs or SNRIs. The onset of effects may also differ from antidepressants. Results vary by individual.
Patients who may benefit include those with treatment-resistant depression, chronic PTSD, anxiety disorders not responding to first-line treatment, OCD, or bipolar depression. Most patients have tried one or more conventional treatments without adequate relief. A new patient evaluation is the first step – no referral required.
The Complete Neuro-Reset is Hudson Mind’s multi-modal protocol combining stellate ganglion block, vagus nerve reset, and IV ketamine therapy — administered in sequence to maximize therapeutic effect. Each treatment builds on the last: the stellate ganglion block calms a hyperactive sympathetic nervous system, the vagus nerve hydrodissection restores parasympathetic balance, and IV ketamine — delivered to a now-settled nervous system — supports neuroplasticity and deeper therapeutic benefit. Designed for patients with complex or co-occurring conditions such as treatment-resistant depression alongside PTSD, with personalized aftercare support through follow-up.
Hudson Mind is located at 281 Broadway, New York, NY 10007 in Lower Manhattan on the 2nd floor. Open Monday through Friday, 9 AM to 5 PM. Closed Saturday and Sunday. Call/text (646) 906-8703 or email mind@hudson.health.
TMS and Spravato therapy are covered by most major insurance plans for treatment-resistant depression. IV ketamine and SGBs are generally not covered, though Hudson Mind provides superbills for potential out-of-network reimbursement claims. We verify benefits for every patient at no cost. See our full pricing page for details.
Each treatment addresses a different neurological pathway.
IV ketamine for treatment-resistant depression, anxiety, and PTSD. Administered over 4–6 sessions in a clinical setting.
FDA-approved, non-invasive magnetic brain stimulation. No medication, no sedation. Covered by most major insurance plans.
A nerve block targeting the sympathetic nervous system. Used for PTSD, anxiety, and trauma-related symptoms.
FDA-Approved esketamine nasal spray for treatment-resistant depression.
Hudson Mind is located at 281 Broadway in Lower Manhattan, serving patients from across New York City, New Jersey, and beyond. A member of our intake team will answer every question — no commitment required..
We see patients for ketamine therapy, stellate ganglion block (SGB), TMS therapy, Spravato, and our Complete Neuro-Reset protocol. Most evaluations are scheduled within the same week.
Address
281 Broadway
New York, NY 10007
Phone/Text
(646) 906-8703
mind@hudson.health
Hours
Mon–Fri: 9 AM – 5 PM Sat–Sun: Closed
Your information is confidential and protected under HIPAA. We typically respond within one business day.
Talk to a member of our intake team before committing to anything. We'll review your history and answer your questions honestly.